BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9641226)

  • 1. Primary sarcoma of the ovary: report of five cases and review of the literature.
    Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
    Eur J Gynaecol Oncol; 1998; 19(3):257-61. PubMed ID: 9641226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed müllerian tumors of the ovary.
    Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcoma in the south of Israel: study of 36 cases.
    Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
    J Surg Oncol; 1997 Jan; 64(1):55-62. PubMed ID: 9040802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different types and different prognosis-study of 310 uterine sarcomas.
    Nickie-Psikuta M; Gawrychowski K
    Eur J Gynaecol Oncol; 1993; 14 Suppl():105-13. PubMed ID: 8200360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
    Eichhorn JH; Young RH; Clement PB; Scully RE
    Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases.
    Menon S; Deodhar K; Rekhi B; Dhake R; Gupta S; Ghosh J; Maheshwari A; Mahantshetty U; Shrivastva S; Budukh A; Tongaonkar HB; Kerkar R
    Indian J Pathol Microbiol; 2013; 56(4):365-71. PubMed ID: 24441223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian leiomyosarcoma: an autopsy case report.
    Nasu M; Inoue J; Matsui M; Minoura S; Matsubara O
    Pathol Int; 2000 Feb; 50(2):162-5. PubMed ID: 10792777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
    Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
    Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
    Tinkler SD; Cowie VJ
    Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
    Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
    Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
    Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
    Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.